Concept explainers
Cervical Cancer Incidence In HPV-Positive Women In 2003, Michelle Khan and her coworkers published their findings on a 10-year study in which they followed cervical cancer incidence and HPV status in 20,514 women. All women who participated in the study were free of cervical cancer when the test began. Pap tests were taken at regular intervals, and the researchers used a DMA probe hybridization test (Section 15.3) to detect specific types of HPV in the women's cervical cells.
The results are shown in FIGURE 37.26 as a graph of the incidence rate of cervical cancer by HPV type. HPV- positive women are often infected by more than one type, so the data were sorted into groups based on the women's HPV status ranked by type: either positive for HPV16; or negative for HPV16 and positive for HPV18; or negative for HPV16 and HPV18 and positive for any other cancer-causing HPV; or negative for all cancer-causing HPV.
Follow-up time (months)
FIGURE 37.26 Cumulative incidence rate of cervical cancer correlated with HPV status in, 20,514 women aged 16 years and cider.
The data were grouped as follows:
● HPV16 positive
○ HFV16 negative and HPV18 positive
▼ All other cancer-causing HPV Types combined
∇ No cancer-causing HPV type was detected.
3. Is it possible to estimate from this graph the overall risk of cervical cancer that is associated with infection of cancer-causing HPV of any type?
Want to see the full answer?
Check out a sample textbook solutionChapter 37 Solutions
Biology: The Unity and Diversity of Life (MindTap Course List)
- A 42-year-old woman comes to the physician for a follow-up examination after two separate Pap smears have shown dysplastic epithelial cells. Results of a molecular diagnostic test show DNA that encodes high-risk versions of the human papillomavirus E6 and E7 proteins. The viral E6 protein binds to the cellular p53 tumor suppressor gene, causing it to be degraded. Which of the following best describes the mechanism by which the E6 protein causes cervical cancer? (A) Arrests the cell cycle (B) Enhances tissue invasion and metastasis (C) Inhibits telomerase expression (D) Prevents apoptosis (E) Sustains angiogenesisarrow_forwardThis is homework not a test! From NTSA case study https://static.nsta.org/case_study_docs/case_studies/cystic_fibrosis.pdf Please help with questions 2, 3 and 4 of part four 2. "The successful use of gene therapy to cure SCID syndrome (2000) is hoped to be a permanent cure for those patients because a good copy of the problem gene was inserted into the patients' blood stem cells in the bone marrow (hematopoietic stem cells). Once white blood cells enter the blood stream they have a limited life span, on the order of a few week to months. The blood stem cells are the cells that create more white blood cells to replace those that are lost. If the gene was only inserted into the circulating mature white blood cells, the patient would only be temporarily cured until those cells were used up or died." The current gene therapy approaches to cure CF involve inserting a functional CFTR gene into the mature epithelial cells of the lungs. In light of the preceding paragraph, do you think that…arrow_forwardFigure 2 shows a comparison of the survival rate of liver transplants in 84 patients who were immunosuppressed with azathioprine and corticosteroids (black) with the survival rate in 55 patients who were immunosuppressed with cyclosporine A and corticosteroids (blue). 100 90 80 70 60 50 40 30 20 10 3 12 24 36 Time after transplantation, months Figure 2 Explain the effects of azathioprine, corticosteroids and cyclosporine A and their combined effects. Distinguish between hyperacute and acute cellular allograft rejections. Survival, %arrow_forward
- You are in the process of developing a monoclonal antibody against an Influenza virus spike protein "H7." You have isolated the B cells producing antibodies against the viral H7 protein and fused those specific B cells with a unique kind of mutant myeloma cells. The myeloma cells can't make any of the three following enzymes; dihydrofolate reductase (DHFR), thymidine kinase (TK), and hypoxanthine-guanosine phosphoribosyl transferase (HGPRT). The mutant unfused myeloma cells are grown in the laboratory in a nucleotide supplemented medium. For selecting the hybridomas, you have used a modified medium HT that does not contain any aminopterin but contains hypoxanthine and thymidine. Which of the following result do you expect to see from your experiment, and what problem you may encounter in the future after the hybridoma selection?arrow_forwardThe head of the oncology divison of a large biotech company proposes to develop a therapeutic antibody to treat cancers with mutant B-Raf oncogene. Is this a good idea? Why or why not(limit 3-4 sentences)?arrow_forwardCOVID-19 has impacted different individuals in varying ways. Much of this has little to do on differing genetics of the body and more to do with social aspects. After learning about social determinants of health please pick three social determinants and explain how they might help or hinder a person who becomes infected by COVID-19.arrow_forward
- 22:23 1O 000 · 11:24 A9 OB1 r ll l 52% . +964 782 734 3923 2m541139927815107... Patient Encounter Part 3 The pretreatment workup is summarized below. Pathology: 47-year-old female with new diagnosis of infiltrating intraductal adenocarcinoma involving the left breast and regional node. Further tests on tumor samples indicated ER (8%), PR (negative), HER2 (negative), Ki-67 (72%), and grade (poorly differentiated). Intrinsic subtype (luminal B, HER2-negative). Radiology: FDG-PET/CT indicated a 5.3 x 2.5 cm mass in the left breast which appeared to extend to the epidermis of the skin; one node in the left axilla was also involved with tumor. No other evidence of distant disease was visualized. Laboratory: CBC, liver, and kidney function tests WNL, alkaline phosphatase and calcium are normal also. Stage: IB (T, N, M,) List the most important prognostic factors in this patient with newly diagnosed breast cancer. Assess the patient's level of risk for relapse. 50 SECTION 16 | ONCOLOGIC…arrow_forward2. https://doi.org/10.1186/s12868-022-00692-1 (link to research) a) In the immunohistochemistry section of the materials and methods section the authors wrote “The number of positive cells in hotspot areas in ten high power fields (HPFs) in areas of demyelination and plaques in the brain stem were counted using the image analysis software (Lecia Application Suite Version 4.12.0, Welzlar, Germany).” Why were they looking at demyelination areas for this study? b) In the effect of mitoxantrone on histopathological changes in the brain section of the results section the authors wrote “Active plaques revealed inflammatory cellular infiltrates with abundant macrophages stuffed with myelin debris, an evidence of ongoing myelin breakdown.” What does macrophages stuffed with myelin debris have to do with the study?arrow_forwardMarie Curie was a famous French-Polish scientist known for her pioneering research on radioactivity. Her work not only brought her fame but her death as well; she developed aplastic anemia due to radiation exposure. She experienced recurrent and prolonged infections (viral, bacterial, parasitic, and fungal). Explain why she suffered from recurrent infections. Be sure to mention the different types of WBC and the relation to the various infections, and the reasons why she lacked the cell-mediated and the humeral response.arrow_forward
- Retroviruses can cause cancer, along with some viruses with DNA genomes. For example, herpes papillomavirus causes cervical cancer. The HPV genome encodes a protein called E6 that interferes with p53 function, and another protein called E7 that inhibits the function of Rb protein. Explain how HPV causes cancer. Are the viral E6 and E7 protein functions more similar to oncogenes or tumor suppressors?arrow_forwardExplain why a vaccine can prevent cervical cancer.arrow_forward Mr. Yeboah, diagnosed with a malignant tumour of the liver had it removed and was given a course of chemotherapy. Initially, tumour marker (AFP) activity activity was 7500KU/L (which is very high) but after treatment, this gradually declined to only 5KU/L. A routine follow up test was perfomedafter 3 months and the results was 15KU/L for AFP. The doctor suspected a relapse of the tumour and so referred Mr. Yeboahto an oncologist at a cancer centre who also did a re-check. AFP was recorded to be 5KU/L. Enquiries revealed that the hospital and the cancer centre use different instruments for the measurement of AFP. Both results are normal even though the values are significantly different because different methods were used.a) How can both labs confirm that the results are not clinically significant? b) How can both labs avoid this happening again?arrow_forward
- Biology: The Dynamic Science (MindTap Course List)BiologyISBN:9781305389892Author:Peter J. Russell, Paul E. Hertz, Beverly McMillanPublisher:Cengage LearningHuman Heredity: Principles and Issues (MindTap Co...BiologyISBN:9781305251052Author:Michael CummingsPublisher:Cengage Learning